Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)

Ziyan Yuan Pessetto; Ying Yan; Tadayoshi Bessho; Amarnath Natarajan

doi:10.1007/s10549-016-3702-6

Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)

Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho, Amarnath Natarajan

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	613
Number of pages	1
Journal	Breast Cancer Research and Treatment
Volume	155
Issue number	3
DOIs	https://doi.org/10.1007/s10549-016-3702-6
State	Published - Feb 1 2016

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1007/s10549-016-3702-6

Cite this

Pessetto, Z. Y., Yan, Y., Bessho, T., & Natarajan, A. (2016). Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4). Breast Cancer Research and Treatment, 155(3), 613. https://doi.org/10.1007/s10549-016-3702-6

Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4). / Pessetto, Ziyan Yuan; Yan, Ying ; Bessho, Tadayoshi et al.
In: Breast Cancer Research and Treatment, Vol. 155, No. 3, 01.02.2016, p. 613.

Research output: Contribution to journal › Comment/debate › peer-review

Pessetto, ZY, Yan, Y , Bessho, T & Natarajan, A 2016, 'Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)', Breast Cancer Research and Treatment, vol. 155, no. 3, pp. 613. https://doi.org/10.1007/s10549-016-3702-6

Pessetto ZY, Yan Y , Bessho T , Natarajan A. Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4). Breast Cancer Research and Treatment. 2016 Feb 1;155(3):613. doi: 10.1007/s10549-016-3702-6

Pessetto, Ziyan Yuan ; Yan, Ying ; Bessho, Tadayoshi et al. / Erratum to : Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4). In: Breast Cancer Research and Treatment. 2016 ; Vol. 155, No. 3. pp. 613.

@article{438af67081b7449db41e722fdd48c652,

title = "Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)",

author = "Pessetto, {Ziyan Yuan} and Ying Yan and Tadayoshi Bessho and Amarnath Natarajan",

year = "2016",

month = feb,

day = "1",

doi = "10.1007/s10549-016-3702-6",

language = "English (US)",

volume = "155",

pages = "613",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Erratum to

T2 - Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)

AU - Pessetto, Ziyan Yuan

AU - Yan, Ying

AU - Bessho, Tadayoshi

AU - Natarajan, Amarnath

PY - 2016/2/1

Y1 - 2016/2/1

UR - http://www.scopus.com/inward/record.url?scp=84959116168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959116168&partnerID=8YFLogxK

U2 - 10.1007/s10549-016-3702-6

DO - 10.1007/s10549-016-3702-6

M3 - Comment/debate

C2 - 26883325

AN - SCOPUS:84959116168

SN - 0167-6806

VL - 155

SP - 613

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -

Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option (Breast Cancer Res Treat, (2012) 134, 511–517, 10.1007/s10549-012-2079-4)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this